COI1 is the E3 ubiquitin ligase for the JAZ degron pathway. This is analogous to the TIR1 enzyme in the auxin pathway, but instead it binds coronatine. Normally, COI1 binds JA-Ile (jasmonic acid-isoleucine) but this compound is difficult and expensive to synthesize and cannot be purchased. Coronatine is structurally similar and is manufactured, which is why we used it instead. COI1 was amplified and verified through gel electrophoresis.
Template:Nevada/TheCoronatineSystem
From 2014.igem.org
Line 295: | Line 295: | ||
<!-- post-content --> | <!-- post-content --> | ||
<div class="post-content"> | <div class="post-content"> | ||
- | <p> | + | <p>COI1 is the E3 ubiquitin ligase for the JAZ degron pathway. This is analogous to the TIR1 enzyme in the auxin pathway, but instead it binds coronatine. Normally, COI1 binds JA-Ile (jasmonic acid-isoleucine) but this compound is difficult and expensive to synthesize and cannot be purchased. Coronatine is structurally similar and is manufactured, which is why we used it instead. COI1 was amplified and verified through gel electrophoresis. </p> |
</div><!-- /post-content --> | </div><!-- /post-content --> | ||
Line 348: | Line 348: | ||
<!-- post-content --> | <!-- post-content --> | ||
<div class="post-content"> | <div class="post-content"> | ||
- | <p>Amplified and tagged | + | <p>Just like we tagged TIR1 with Myc, here we tagged COI1 with an HA tag for screening. Amplified and tagged COI1 was then joined to pTEF-GFP, inserted into a bacterial vector and transformed with NEB 10 beta competent cells with LB-ampicillin selection. You may have noticed that we use GFP in both of our systems, though we said our goal was a bioorthogonal system to degrade two proteins simultaneously. At the beginning, our use of RFP was not very successful, so for the interest of making sure we can build a construct that works, we used what we had which was GFP and will later swap it out for mCherry when we juxtapose the systems into yeast. </p> |
</div><!-- /post-content --> | </div><!-- /post-content --> | ||
Line 403: | Line 403: | ||
<!-- post-content --> | <!-- post-content --> | ||
<div class="post-content"> | <div class="post-content"> | ||
- | <p>After | + | <p>After the above construct grew successful colonies, we isolated and purified the newly engineered vector and transformed into W303 yeast cells. It was screened via yeast colony PCR.</p> |
</div><!-- /post-content --> | </div><!-- /post-content --> | ||
Line 444: | Line 444: | ||
<div class="post-title"> | <div class="post-title"> | ||
<h2> | <h2> | ||
- | <a title="Confirmation of | + | <a title="Confirmation of COI1 expression in yeast"> |
- | <b>Confirmation of | + | <b>Confirmation of COI1 expression in yeast</b> |
</a> | </a> | ||
</h2> | </h2> | ||
Line 459: | Line 459: | ||
<!-- post-content --> | <!-- post-content --> | ||
<div class="post-content"> | <div class="post-content"> | ||
- | <p> | + | <p>Protein was extracted from yeast via alkali treatment and analyzed on a Western blot and Coomassie blue assay. </p> |
</div><!-- /post-content --> | </div><!-- /post-content --> | ||
Revision as of 21:19, 17 October 2014
Just like we tagged TIR1 with Myc, here we tagged COI1 with an HA tag for screening. Amplified and tagged COI1 was then joined to pTEF-GFP, inserted into a bacterial vector and transformed with NEB 10 beta competent cells with LB-ampicillin selection. You may have noticed that we use GFP in both of our systems, though we said our goal was a bioorthogonal system to degrade two proteins simultaneously. At the beginning, our use of RFP was not very successful, so for the interest of making sure we can build a construct that works, we used what we had which was GFP and will later swap it out for mCherry when we juxtapose the systems into yeast.
After the above construct grew successful colonies, we isolated and purified the newly engineered vector and transformed into W303 yeast cells. It was screened via yeast colony PCR.
Protein was extracted from yeast via alkali treatment and analyzed on a Western blot and Coomassie blue assay.